Plancorp LLC’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,422
| Closed | -$595K | – | 241 |
|
|
2022
Q3 | $595K | Sell |
2,422
-393
| -14% | -$106K | 0.04% | 132 |
|
|
2022
Q2 | $697K | Sell |
2,815
-194
| -6% | -$52.4K | 0.04% | 122 |
|
|
2022
Q1 | $997K | Sell |
3,009
-398
| -12% | -$123K | 0.06% | 99 |
|
|
2021
Q4 | $1.22M | Buy |
3,407
+2
| +0.1% | +$676 | 0.08% | 89 |
|
|
2021
Q3 | $1.11M | Sell |
3,405
-400
| -11% | -$136K | 0.08% | 87 |
|
|
2021
Q2 | $1.19M | Sell |
3,805
-400
| -10% | -$123K | 0.09% | 81 |
|
|
2021
Q1 | $1.34M | Sell |
4,205
-400
| -9% | -$128K | 0.3% | 60 |
|
|
2020
Q4 | $1.49M | Buy |
4,605
+4
| +0.1% | +$1.11K | 0.37% | 53 |
|
|
2020
Q3 | $1.27M | Hold |
4,601
| – | – | 0.39% | 52 |
|
|
2020
Q2 | $1.11M | Hold |
4,601
| – | – | 0.33% | 56 |
|
|
2020
Q1 | $668K | Buy |
4,601
+14
| +0.3% | +$2.32K | 0.26% | 71 |
|
|
2019
Q4 | $782K | Hold |
4,587
| – | – | 0.24% | 78 |
|
|
2019
Q3 | $816K | Hold |
4,587
| – | – | 0.31% | 61 |
|
|
2019
Q2 | $1.2M | Sell |
4,587
-9
| -0.2% | -$2.39K | 0.47% | 44 |
|
|
2019
Q1 | $1.31M | Buy |
4,596
+9
| +0.2% | +$2.99K | 0.5% | 49 |
|
|
2018
Q4 | $1.49M | Hold |
4,587
| – | – | 0.68% | 37 |
|
|
2018
Q3 | $2.06M | Hold |
4,587
| – | – | 0.81% | 27 |
|
|
2018
Q2 | $1.88M | Hold |
4,587
| – | – | 0.75% | 29 |
|
|
2018
Q1 | $1.33M | Hold |
4,587
| – | – | 0.43% | 40 |
|
|
2017
Q4 | $860K | Hold |
4,587
| – | – | 0.28% | 64 |
|
|
2017
Q3 | $773K | Hold |
4,587
| – | – | 0.23% | 67 |
|
|
2017
Q2 | $657K | Hold |
4,587
| – | – | 0.2% | 80 |
|
|
2017
Q1 | $574K | Hold |
4,587
| – | – | 0.17% | 89 |
|
|
2016
Q4 | $517K | Buy |
+4,587
| New | +$531K | 0.15% | 91 |
|
|
2016
Q1 | – | Sell |
-4,587
| Closed | -$414K | – | 81 |
|
|
2015
Q4 | $414K | Hold |
4,587
| – | – | 0.49% | 50 |
|
|
2015
Q3 | $425K | Buy |
+4,587
| New | +$404K | 0.39% | 58 |
|
|
2015
Q2 | – | Sell |
-5,087
| Closed | -$364K | – | 111 |
|
|
2015
Q1 | $364K | Buy |
+5,087
| New | +$276K | 0.36% | 63 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Plancorp LLC's ABMD Position: Q4 2022 in Review
Plancorp LLC sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,422 shares — an estimated $595K sold.
Plancorp LLC first reported a position in ABMD in Q1 2015 and held it in 27 quarters. The position peaked at $2.06M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Plancorp LLC reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Plancorp LLC sold 2,422 Abiomed Inc shares in Q4 2022, an estimated $595K.
- Plancorp LLC first reported a position in Abiomed Inc in Q1 2015 and held it in 27 quarters.
- Plancorp LLC's Abiomed Inc position peaked at $2.06M in Q3 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Plancorp LLC's 13F filing for Q4 2022, filed 14 Feb 2023.